Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Covidien Aims To Double Sales In Emerging Markets By 2017

This article was originally published in PharmAsia News

Executive Summary

Covidien plans to double its sales in emerging markets, primarily China and India, to $2 billion over the next five to six years, CEO Jose E. Almeida said during the firm's Sept. 8 investor meeting in New York
Advertisement

Related Content

Emerging Views On Emerging Markets: Goldman Sachs Global Healthcare Conference
Trends In MIS, Part I: Pushing Surgical Boundaries
Stryker Buys Concentric Medical To Enter Acute Ischemic Stroke Market
Medtronic Growth Plan: Boost R&D Productivity, Globalization
Medtronic Growth Plan: Boost R&D Productivity, Globalization
News In Brief
Earnings Calls In Brief
News In Brief
Advertisement
UsernamePublicRestriction

Register

SC079030

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel